AI Article Synopsis

  • * An innovative method using automated pipetting with a liquid-handling robot was developed to allow high-throughput testing of phages, making the process more efficient than traditional manual assays.
  • * Results showed that the automated method had better consistency and lower variation in results, which could help to standardize the evaluation of phage potency across different samples.

Article Abstract

The development of bacteriophages (phages) as active pharmaceutical ingredients for the treatment of patients is on its way and regulatory agencies are calling for reliable methods to assess phage potency. As the number of phage banks is increasing, so is the number of phages that need to be tested to identify therapeutic candidates. Currently, assessment of phage potency on a semi-solid medium to observe plaque-forming units is unavoidable and proves to be labor intensive when considering dozens of phage candidates. Here, we present a method based on automated pipetting and phage drop-off performed by a liquid-handling robot, allowing high-throughput testing and phage potency determination (based on phage titer and efficiency of plaquing). Ten phages were tested, individually and assembled into one cocktail, against 126 strains. This automated method was compared to the reference one (manual assay) and validated in terms of reproducibility and concordance (ratio of results according to the Bland and Altman method: 0.99; Lin's concordance correlation coefficient: 0.86). We found that coefficients of variation were lower with automated pipetting (mean CV: 13.3% vs. 24.5%). Beyond speeding up the process of phage screening, this method could be used to standardize phage potency evaluation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10886619PMC
http://dx.doi.org/10.3390/biomedicines12020466DOI Listing

Publication Analysis

Top Keywords

phage potency
16
automated pipetting
12
phage
10
potency determination
8
pipetting phage
8
phage drop-off
8
phages tested
8
potency
5
method
5
high-throughput bacteriophage
4

Similar Publications

Bacteriophages, known for their ability to kill bacteria, are hampered in their effectiveness because bacteria are able to rapidly develop resistance, thereby posing a significant challenge for the efficacy of phage therapy. The impact of evolutionary trajectories on the long-term success of phage therapy remains largely unclear. Herein, we conducted evolutionary experiments, genomic analysis, and CRISPR-mediated gene editing, to illustrate the evolutionary trajectory occurring between phages and their hosts.

View Article and Find Full Text PDF

A deep mutational scanning platform to characterize the fitness landscape of anti-CRISPR proteins.

Nucleic Acids Res

December 2024

Institute of Pharmacy and Molecular Biotechnology (IPMB), Faculty of Engineering Sciences, Heidelberg University, Heidelberg 69120, Germany.

Deep mutational scanning is a powerful method for exploring the mutational fitness landscape of proteins. Its adaptation to anti-CRISPR proteins, which are natural CRISPR-Cas inhibitors and key players in the co-evolution of microbes and phages, facilitates their characterization and optimization. Here, we developed a robust anti-CRISPR deep mutational scanning pipeline in Escherichia coli that combines synthetic gene circuits based on CRISPR interference with flow cytometry coupled sequencing and mathematical modeling.

View Article and Find Full Text PDF

Therapeutic Interventions for Infections in Cystic Fibrosis Patients: A Review of Phase IV Trials.

J Clin Med

October 2024

Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra 11961, Saudi Arabia.

() poses a significant threat to individuals with cystic fibrosis (CF), as this bacterium is highly adaptable and resistant to antibiotics. While early-stage infections can often be eradicated with aggressive antibiotic therapy, chronic infections are nearly impossible to eliminate and require treatments that focus on long-term bacterial suppression. Without such suppression, these persistent infections can severely damage the lungs, leading to serious complications and a reduced life expectancy for CF patients.

View Article and Find Full Text PDF
Article Synopsis
  • Notch is important for development and diseases, leading researchers to create inhibitors using small molecules and antibodies.* -
  • A novel nanobody was developed to inhibit Notch signaling, showing effectiveness in laboratory assays despite a low affinity for the Notch target.* -
  • By linking the nanobody to a toxin-derived membrane domain, researchers improved its potency, successfully inhibiting cancer cell proliferation similar to existing Notch blockers.*
View Article and Find Full Text PDF

Identification of a potent SARS-CoV-2 neutralizing nanobody targeting the receptor-binding domain of the spike protein.

Int J Biol Macromol

November 2024

Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, Frontiers Science Center for Synthetic Biology, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin 300072, China; Department of Molecular Pharmacology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China; Haihe Laboratory of Sustainable Chemical Transformations, Tianjin 300192, China. Electronic address:

Article Synopsis
  • - SARS-CoV-2 and its variants remain a major threat to public health, prompting research into potential treatments like nanobodies (Nbs) that block the virus from entering host cells.
  • - A study identified sixteen candidate Nbs from an alpaca library, with nine showing strong binding and neutralizing activity against SARS-CoV-2, particularly NbS4, which had the best effectiveness.
  • - The crystal structure analysis revealed that NbS4 binds closely to the ACE2 site on the virus's spike protein, and its key binding residues are largely conserved across various SARS-CoV-2 variants, highlighting its potential for future therapies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!